🇺🇸 FDA
Patent

US 11851656

Chemically modified single-stranded RNA-editing oligonucleotides

granted A61PA61P1/04A61P11/06

Quick answer

US patent 11851656 (Chemically modified single-stranded RNA-editing oligonucleotides) held by ProQR Therapeutics II B.V. expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ProQR Therapeutics II B.V.
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61P, A61P1/04, A61P11/06, A61P17/00, A61P21/00